In July 2025, the resolution by the Federal Council for Medicine was blocked by a federal judge. This allowed the previous resolution, which was issued in 2020 and granted access to puberty blockers and hormone replacement therapy to those above 16 years old - with parental approval required for those under 18 - and sex reassignment surgeries to those above 18 years old through the Brazilian public healthcare system, to go back into effect immediately. resolution from 2020 that granted access to puberty blockers and hormone replacement therapy to those above 16 years old - with parental approval required for those under 18 - and sex reassignment surgeries to those above 18 years old through the Brazilian public healthcare system, to go back into effect immediately.

In April 2025, Brazil’s Federal Council for Medicine issued a new resolution raising the minimum age for hormone replacement therapy from 16 to 18 and the minimum age for surgeries from 18 to 21, banning its care to youth. The resolution, however, was challenged in court and blocked by a federal judge, making the previous resolution, which was issued in 2020 and granted access to puberty blockers and hormone replacement therapy to those above 16 years old - with parental approval required for those under 18 - and sex reassignment surgeries to those above 18 years old through the Brazilian public healthcare system, take effect immediately. July 2025, the resolution by the Federal Council for Medicine was blocked by a federal judge. This allowed the previous resolution, which was issued in 2020 and granted access to puberty blockers and hormone replacement therapy to those above 16 years old - with parental approval required for those under 18 - and sex reassignment surgeries to those above 18 years old through the Brazilian public healthcare system, to go back into effect immediately.

In 2025, Brazil’s Federal Council for Medicine issued a new resolution raising the minimum age for hormone therapy to 18 and the minimum age for surgeries to 21, banning its care to youth. This does not effect those already undergoing such care. April 2025, Brazil’s Federal Council for Medicine issued a new resolution raising the minimum age for hormone replacement therapy from 16 to 18 and the minimum age for surgeries from 18 to 21, banning its care to youth. The resolution, however, was challenged in court and blocked by a federal judge, making the previous resolution, which was issued in 2020 and granted access to puberty blockers and hormone replacement therapy to those above 16 years old - with parental approval required for those under 18 - and sex reassignment surgeries to those above 18 years old through the Brazilian public healthcare system, take effect immediately.